Plantar Fasciitis Treatment Market by Type and Forecast to 2027

1
Type Medication Therapy, Orthotics, Shockwave
Therapy, Surgery, and Others End User
Hospitals, Clinics, and OthersForecast From 2019
- 2027
Plantar Fasciitis Treatment Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Plantar Fasciitis Treatment Market
Chapter 4 Market Overview
Chapter 5 Market Outlook
Chapter 6 Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type 
Chapter 7 Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End User 
Chapter 8 Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region
Chapter 9 North America Plantar Fasciitis Treatment Market Analysis and Forecast
Chapter 10 Europe Plantar Fasciitis Treatment Market Analysis and Forecast
Chapter 11 Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast
Chapter 12 Latin America Plantar Fasciitis Treatment Market Analysis and Forecast
Chapter 13 Middle East Africa Plantar Fasciitis Treatment Market Analysis and Forecast
Chapter 14 Competition Landscape

3
Plantar Fasciitis Treatment Market Snapshot

• Plantar fasciitis is one of the most common foot
  pain conditions. Plantar fasciitis is primarily
  caused due to repetitive strain on the ankle,
  leading to progressive wear and tear and
  degeneration of plantar fascia, a thick
  connective tissue covering the lower side of the
  foot.
• The multi-factorial etiology of plantar fasciitis
  has led to a significant surge in the number of
  sufferers, while laying a firm base for the
  growth of companies that provide treatment for
  this condition.
• Key Players - Hanger, Inc., Bayer Group (Dr.
  Scholl's), A. Algeo Limited, Bauerfeind AG,
  Superfeet Worldwide, Inc., Ottobock SE Co. KGaA
  (Ottobock Holding), Pfizer, Inc., Sanofi, and
  GlaxoSmithKline plc.

4
(No Transcript)
5
Reports Highlights

• The global plantar fasciitis treatment market was
  valued at US 695 Mn in 2018, and is projected
  to expand at a CAGR of 4.3 from 2019 to 2027. .
• Rise in the number of individuals living
  sedentary lifestyles coupled with changes in
  eating habits leads to an increase in obesity,
  which puts pressure on the joints and ankles, and
  can result in plantar fasciitis.
• Increase in the percentage of geriatric and obese
  populations is likely to propel the number of
  patients suffering from plantar fasciitis.
• Increase in the number of patients suffering from
  plantar fasciitis, and rise in the number of
  patients coming in through reimbursement programs
  such as Medicare.

Request Sample
6
(No Transcript)